TipRanks
Advertisement
Advertisement

CH:ATRA Stock Latest News

Atara reports resubmission of tabelecleucel BLA to FDA
The FlyAtara reports resubmission of tabelecleucel BLA to FDA
2d ago
ATRA
Atara Biotherapeutics reports Q2 EPS (32c), consensus (32c)
PremiumThe Fly
Atara Biotherapeutics reports Q2 EPS (32c), consensus (32c)
2M ago
ATRA
Atara Bio sees cash, equivalents sufficient to fund operations into mid-2027
PremiumThe Fly
Atara Bio sees cash, equivalents sufficient to fund operations into mid-2027
2M ago
ATRA
Atara Biotherapeutics’ Executive Turnover and Workforce Cuts Elevate Execution Risk and Threaten Strategic Progress
PremiumCompany Announcements
Atara Biotherapeutics’ Executive Turnover and Workforce Cuts Elevate Execution Risk and Threaten Strategic Progress
2M ago
ATRA
ATRA Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
ATRA Upcoming Earnings Report: What to Expect?
2M ago
ATRA
Atara Biotherapeutics Adds Independent Director to Board
PremiumCompany AnnouncementsAtara Biotherapeutics Adds Independent Director to Board
4M ago
8K
ATRA
Atara Biotherapeutics upgraded to Hold from Sell at Freedom Broker
Premium
The Fly
Atara Biotherapeutics upgraded to Hold from Sell at Freedom Broker
5M ago
ATRA
Manufacturing and Supply-Chain Risks Threaten Atara Biotherapeutics’ Cell Therapy Pipeline
Premium
Company Announcements
Manufacturing and Supply-Chain Risks Threaten Atara Biotherapeutics’ Cell Therapy Pipeline
5M ago
ATRA
Atara Biotherapeutics reports Q1 EPS -29c, consensus -22c
PremiumThe Fly
Atara Biotherapeutics reports Q1 EPS -29c, consensus -22c
5M ago
ATRA
Atara Biotherapeutics upgraded to Buy from Hold at Canaccord
PremiumThe Fly
Atara Biotherapeutics upgraded to Buy from Hold at Canaccord
5M ago
ATRA
Atara Biotherapeutics trading halted, volatility trading pause
PremiumThe Fly
Atara Biotherapeutics trading halted, volatility trading pause
5M ago
ATRA
Atara Biotherapeutics jumps 70%, or $3.60, to $8.75
PremiumThe Fly
Atara Biotherapeutics jumps 70%, or $3.60, to $8.75
5M ago
ATRA
Atara Biotherapeutics trading resumes
PremiumThe FlyAtara Biotherapeutics trading resumes
5M ago
ATRA
Atara Biotherapeutics Gains Clearer FDA Path for Tab-cel
Premium
Company Announcements
Atara Biotherapeutics Gains Clearer FDA Path for Tab-cel
5M ago
8K
ATRA
Atara says PFP had productive meeting with FDA
Premium
The Fly
Atara says PFP had productive meeting with FDA
5M ago
ATRA
ATRA Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
ATRA Upcoming Earnings Report: What to Expect?
5M ago
ATRA
Atara Biotherapeutics Receives Nasdaq Non-Compliance Delisting Notice
PremiumCompany Announcements
Atara Biotherapeutics Receives Nasdaq Non-Compliance Delisting Notice
5M ago
8K
ATRA
Atara Biotherapeutics files to sell 400K shares of common stock for holders
PremiumThe Fly
Atara Biotherapeutics files to sell 400K shares of common stock for holders
7M ago
ATRA
Atara provides update on tabelecleucel biologics license application
PremiumThe Fly
Atara provides update on tabelecleucel biologics license application
7M ago
ATRA
Atara Plans FDA Type A Meeting on EBVALLO
PremiumCompany AnnouncementsAtara Plans FDA Type A Meeting on EBVALLO
7M ago
8K
ATRA
Atara, Pierre Fabre seek FDA meeting on EBVALLO
Premium
Company Announcements
Atara, Pierre Fabre seek FDA meeting on EBVALLO
7M ago
8K
ATRA
Atara Biotherapeutics partner submits Type A meeting request to FDA
Premium
The Fly
Atara Biotherapeutics partner submits Type A meeting request to FDA
7M ago
ATRA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >